Milestone Scientific (MLSS) Cash & Equivalents (2010 - 2026)

Milestone Scientific has disclosed Cash & Equivalents across 17 years of filings, most recently posting $1.2 million for Q1 2026.

• Cash & Equivalents for Q1 2026 came in at $1.2 million, down 46.83% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.2 million (down 46.83% YoY), and the FY2025 annual result was $1.1 million, down 65.85% from the prior year.
• Cash & Equivalents came in at $1.2 million for Q1 2026 at Milestone Scientific, up from $1.1 million in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $13.3 million in Q1 2022 to a low of $1.1 million in Q4 2025.
• The 5-year median for Cash & Equivalents is $3.3 million (2024), against an average of $4.6 million.
• Across the five-year window, Cash & Equivalents plunged 82.81% in 2023 and jumped 120.01% in 2024, its largest moves.
• Milestone Scientific's Cash & Equivalents stood at $8.7 million in 2022, then sank by 65.83% to $3.0 million in 2023, then grew by 9.41% to $3.3 million in 2024, then slumped by 65.85% to $1.1 million in 2025, then grew by 7.35% to $1.2 million in 2026.
• The last three Cash & Equivalents figures came in at $1.2 million (Q1 2026), $1.1 million (Q4 2025), and $1.3 million (Q3 2025), per Business Quant data.